Journal of Endourology · 2009 · 64 citations · 16 references
MedicineRadiologySurgeryDiagnostic ImagingDiagnostic RadiologyInterventional RadiologyAblation TherapyImage-guided Tumor AblationRenal Cell CarcinomaRenal ImagingRenal Mass EvaluationTumor ImagingAblation Of Renal MassesComputed Tomography-guided AblationContrast-enhanced Computed TomographyLesion Enhancement AssessmentLocal Tumor RecurrencePercutaneous AblationRenal Mass AblationRenal Tumor Ablation
INTRODUCTION: Percutaneous renal ablation is often performed under conscious sedation and without contrast-enhanced imaging. We evaluated intermediate-term outcomes of patients undergoing percutaneous contrast-enhanced computed tomography (CT)-guided radiofrequency ablation (RFA) under general anesthesia (GA) at two high-volume centers. MATERIALS AND METHODS: Prospectively maintained Institutional Regulatory Board-approved databases were searched to identify patients treated with percutaneous RFA using contrast-enhanced CT under GA. A total of 163 masses in 151 patients were treated. Enhancement on imaging or a positive biopsy at 4 to 6 weeks was considered incomplete ablation. Positive findings beyond this interval were defined as local recurrence. RESULTS: The median follow-up was 18 months (range, 1.5-70). Median tumor size was 2.3 cm (range, 1-5.4). Of the 130 (80%) masses with definitive pathology, 70% were renal cell cancer. Five masses had evidence of viable tumor at 4 to 6 weeks posttreatment for a complete initial ablation rate of 97%. Three of these five lesions were endophytic. Five masses (3.3%) showed evidence of local recurrence, and metastases developed in two patients (1.3%). Overall 1- and 3-year recurrence-free survival was 97% and 92%, respectively. Masses that were in the central region and were endophytic had the highest risk for recurrence (hazard ratio, 6.3; p = 0.016). CONCLUSIONS: Intermediate-term outcomes of percutaneous RFA are excellent. GA-assisted, contrast-enhanced CT-guided percutaneous RFA demonstrates a high initial ablation success rate. However, endophytic and interpolar lesions are at higher risk for recurrence.
16
Debra A. Gervais, Francis J. McGovern, Ronald S. Arellano et al. · American Journal of Roentgenology · 2005 · 588 citations
Imaging-Guided Radiofrequency Ablation of Solid Renal Tumors
Michael A. Farrell, William J. Charboneau, David S. DiMarco et al. · American Journal of Roentgenology · 2003 · 262 citations
William W. Mayo-Smith, Damian E. Dupuy, Pranay M. Parikh et al. · American Journal of Roentgenology · 2003 · 262 citations